Primary healthcare providers’ perspectives on six-month dispensing of antiretroviral therapy (ART) in South Africa: cross-sectional survey of views and preferences
Sign Up to like & getrecommendations! Published in 2025 at "Global Health Action"
DOI: 10.1080/16549716.2025.2484111
Abstract: ABSTRACT Background Many African countries have increased the dispensing duration of antiretroviral therapy (ART) from 3 months to 6 months for established HIV treatment clients. Objective To assess South African healthcare providers’ views on the benefits and… read more here.
Keywords: healthcare providers; month; south africa; primary healthcare ... See more keywords
Effect of Dolutegravir and multi-month dispensing on viral suppression among children with HIV.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of acquired immune deficiency syndromes"
DOI: 10.1097/qai.0000000000003190
Abstract: BACKGROUND Few studies in sub-Saharan Africa have assessed the impact of multi-month dispensing (MMD) of antiretroviral therapy (ART) and dolutegravir (DTG) beyond clinical trials among children with HIV (CWHIV). We assessed the effect of the… read more here.
Keywords: month dispensing; effect; among children; dtg ... See more keywords
Estimating the cost and efficiency gain of rolling out a multi-month dispensing programme for antiretroviral treatment in Tanzania
Sign Up to like & getrecommendations! Published in 2022 at "African Journal of AIDS Research"
DOI: 10.2989/16085906.2022.2133619
Abstract: Background: Globally, efforts to curtail the HIV pandemic are growing. The Joint United Nations Programme on HIV and AIDS (UNAIDS) and partners set the 95-95-95 targets to be achieved by 2025. Tanzania’s ongoing transition from… read more here.
Keywords: month dispensing; cost; month; tanzania ... See more keywords